• 제목/요약/키워드: CHO cell

검색결과 5,380건 처리시간 0.042초

The efficient Erythropoietin expression system in Chinese Hamster Ovary cells by introduction of urea cycle enzymes

  • Lee, Yun-Jeong;Kim, Jung-Kwon;Kim, Hyung-Jin;Kim, Na-Young;Kim, Jung-Hoe;Kim, Hong-Jin
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
    • /
    • pp.231.2-231.2
    • /
    • 2003
  • The efficient EPO (Erythropoietin) expression system in Chinese Hamster Ovary (CHO) cells was devised through the removal of ammonium ion accumulated in the media by introducing urea cycle enzymes. Previously, we developed C05 cell by transfecting the carbamoly phosphate synthase (CPS) and ornithine transcarbamoylase (OTC) into the EPO expressing CHO cell, IBE. (omitted)

  • PDF

동물세포 배양액으로부터 암모늄 이온의 동시제거를 위한 고정화 흡착제의 개발과 동물세포 배양 시스템에의 응용: I. 고정화 흡착시스템 개발 (Development of an Immobilized Adsorbent for in situ Removal of Ammonium Ion from Mammalian Cell Culture Media and its Application to a Mammalian Cell Bioreactor: I. Development of Immobilized Adsorbent System)

  • 박병곤;민용원;전계택;김익환;정연호
    • KSBB Journal
    • /
    • 제13권4호
    • /
    • pp.404-410
    • /
    • 1998
  • CHO 세포외 성장 및 생산성을 저해하는 엄포늄 이온의 동시 제거를 위해 PhJlhpsite~Gismondine 합성 zeolite가 alginate, cellulose acetate. dialysis membrane에 고정화된 흡착제가 개발되었다. 고정화 흡착체에 의한 암모늄 이온의 제거 효율 및 비에 따른 세표성장의 증진효과를 비교한 결과 최적의 고정화 흡착제로 membrane type이 선정되었다. 암모늄 이온의 제거 효파를 더욱더 명확하게 하고 고멸도의 세포 배양을 모사하가 위하여 8mM의 ammonium chloride를 첨가하고 membrane type 고정화 흡착제를 투여하여 암모늄 이온의 동시제거 효과를 조사한 결과 최대 세포 농도가 3배 이상 증가하였으며 생존율 역시 증가하였고 40%정도의 tPA 생산성 향상올 보여 주었다­. 이러한 증진 효과는 암모늄 이온의 고농도 시스템일수록 커졌다. 고정화 흡착제의 최적 투며 시기를 조사해본 결과 ammonium chlonde를 첨가하지 않았을 때 membrane type 고 정화 흡착제의 최적 투여 시기는 배양 시작 후 48시간이었고, 8mM의 ammonium chloride를 침가한 경우의 최적 투여 시기는 배양 시작 후 72시간이었다.

  • PDF

무혈청 배지를 이용한 CHO 세포의 동결보존 (Cryopreservation of CHO Cell using Serum-Free Media)

  • 김유강;박홍우;최태부
    • KSBB Journal
    • /
    • 제21권2호
    • /
    • pp.110-117
    • /
    • 2006
  • 일반적인 세포주의 동결보존은 혈청이 첨가된 배양배지에 10% DMSO를 첨가하여 실행하게 된다. 그러나 무혈청 환경에서 배양되는 세포주를 이용하여 생물의약품을 생산하는 공정에 사용되는 세포주의 경우는 교차오염 방지를 위해 동결보존 역시 혈청을 제거한 상태에서 실시되어야 한다. 본 실험은 무혈청 동결보존이 CHO 세포에 어떠한 영향을 미치는지 알아보기 위하여 실시되었다. 우선, 무혈청 동결보존에서 세포 생존율을 높이기 위해 투과성 및 비투과성 첨가제를 배지에 첨가하는 방법으로 동결보존 및 해동하여 생존율을 측정하였다. 그 결과, 10% DMSO와 0.03 M raffinose를 동시에 첨가한 경우에 76%의 생존율을 확보할 수 있었지만 기존의 혈청을 이용하는 동결보존에는 미치지 못하였다. 두 번째로 무혈청 배지의 동결보존 능력을 알아보기 위해 시판 중인 무혈청 배지와 무혈청 동결보존제를 사용하여 동결 보존 후의 생존율을 비교한 결과, 무혈청 배지를 이용한 실험에서는 혈청 배지를 이용한 동결보존과 유사한 95% 이상의 생존율을 확인할 수 있었다. 이는 무혈청 동결보존제의 동결보존 능력보다 우수한 결과이다. 마지막으로 무혈청 배지를 이용한 장기간 동결보존에서 CHO 세포의 안정성을 확인하기 위하여 무혈청 배지로 동결보존된 CHO 세포를 3개월 단위로 해동하여 생존율 및 성장 회복율을 측정하고, real-time RT-PCR을 통해 삽입된 CHO DHFR 유전자의 안정성을 평가하였다. 혈청배지와 비교할 때, 생존율과 성장 회복율, 유전자 안정성 측면에서 모두 동일한 결과를 보여, 무혈청 배지를 이용한 18개월 이상의 동결보존이 안정적임을 검증할 수 있었다. 결과적으로 생물의약품 공정에서 무혈청 배지를 이용한 동결보존이 혈청을 이용한 동결보존을 대체할 수 있을 것으로 생각된다.

Regulation of Th2 Cell Immunity by Dendritic Cells

  • Hyeongjin Na;Minkyoung Cho;Yeonseok Chung
    • IMMUNE NETWORK
    • /
    • 제16권1호
    • /
    • pp.1-12
    • /
    • 2016
  • Th2 cell immunity is required for host defense against helminths, but it is detrimental in allergic diseases in humans. Unlike Th1 cell and Th17 cell subsets, the mechanism by which dendritic cells modulate Th2 cell responses has been obscure, in part because of the inability of dendritic cells to provide IL-4, which is indispensable for Th2 cell lineage commitment. In this regard, immune cells other than dendritic cells, such as basophils and innate lymphoid cells, have been suggested as Th2 cell inducers. More recently, multiple independent researchers have shown that specialized subsets of dendritic cells mediate Th2 cell responses. This review will discuss the current understanding related to the regulation of Th2 cell responses by dendritic cells and other immune cells.

Adjuvant role of macrophages in stem cell-induced cardiac repair in rats

  • Lim, Soo yeon;Cho, Dong Im;Jeong, Hye-yun;Kang, Hye-jin;Kim, Mi Ra;Cho, Meeyoung;Kim, Yong Sook;Ahn, Youngkeun
    • Experimental and Molecular Medicine
    • /
    • 제50권11호
    • /
    • pp.1.1-1.10
    • /
    • 2018
  • Bone marrow-derived mesenchymal stem cells (BMMSCs) are used extensively for cardiac repair and interact with immune cells in the damaged heart. Macrophages are known to be modulated by stem cells, and we hypothesized that priming macrophages with BMMSCs would enhance their therapeutic efficacy. Rat bone marrow-derived macrophages (BMDMs) were stimulated by lipopolysaccharide (LPS) with or without coculture with rat BMCs. In the LPS-stimulated BMDMs, induction of the inflammatory marker iNOS was attenuated, and the anti-inflammatory marker Arg1 was markedly upregulated by coculture with BMMSCs. Myocardial infarction (MI) was induced in rats. One group was injected with BMMSCs, and a second group was injected with MIX (a mixture of BMMSCs and BMDMs after coculture). The reduction in cardiac fibrosis was greater in the MIX group than in the BMC group. Cardiac function was improved in the BMMSC group and was substantially improved in the MIX group. Angiogenesis was better in the MIX group, and anti-inflammatory macrophages were more abundant in the MIX group than in the BMMSC group. In the BMMSCs, interferon regulatory factor 5 (IRF5) was exclusively induced by coculture with macrophages. IRF5 knockdown in BMMSCs failed to suppress inflammatory marker induction in the macrophages. In this study, we demonstrated the successful application of BMDMs primed with BMMSCs as an adjuvant to cell therapy for cardiac repair.

형질전환 CHO-K1 세포주를 이용한 EPO의 생산에서 zinc ion이 미치는 영향

  • 이경선;김동일
    • 한국생물공학회:학술대회논문집
    • /
    • 한국생물공학회 2002년도 생물공학의 동향 (X)
    • /
    • pp.309-312
    • /
    • 2002
  • GS system을 이용하여 재조합 EPO를 생산하는 새로운 CHO-K1 세포주를 확립하였으며, 이 세포주를 이용하여 Zn 이온과 Mn 이온이 EPO의 생산에 미치는 영향에 관해서 연구하였다. 형질 전환에 있어서 DNA 3 ${\mu}g$ 올 사용하고, 세포군 선별을 위한 MSX의 농도는 100 11M 을 사용한 경우에만 세포군이 발견되었다. 200 ${\mu}M$의 MSX를 처리한 경우에서는 세포군이 생성되지 않았고, 이는 고농도의 MSX에 의해 세포 생장이 저해되었기 때문이다. 형질 전환된 CHO-K1 세포 배양에 Zn 이온을 첨가한 결과 세포의 생장은 크게 저해되지 않은 반연에, EPO의 생산은 대조구에 비해 40% 이상 증가함을 알 수 있었다. 이러한 결과는 Mn 이온을 처리한 실험에서도 관찰할 수 있었다.

  • PDF

Effects of Mutagenesis for Glycosylation Sites of Recombinant Human EPO During Production from Cultured CHO Cell

  • Lee, Hyun-Gi;Seong, Hwan-Hoo;Im, Seok-Ki;Chung, Hee-Kyoung;Lee, Poongyeon;Lee, Yeun-Kun;Min, Kwan-Sik;Chang, Won-Kyoung;Lee, Hoon-Taek
    • 한국수정란이식학회:학술대회논문집
    • /
    • 한국수정란이식학회 2002년도 국제심포지엄
    • /
    • pp.97-97
    • /
    • 2002
  • Human eryhropoietin (EPO) is acidic glycoprotein hormone that plays key role in hematopoiesis by facilitating differentiation of erythrocyte and formation of hemoglobin (Hb) and is used for the treatment of anemia. Human EPO is consist of 166 amino acids which is modified by three N-glycosylations (24, 38, 83) and single O-glycosylation (126). N-glycosylation is reported to be related to the cellular secretion and activity of EPO. In this study, we examined effects of mutagenesis in glycosylation site of recombinat hEPO for the cellular secretion during production from cultured CHO cell. We produced rhEpo which was cloned by PCR from human liver cDNA (TaKaRa) in cultured CHO cell. Using supernatant of the culture, ELISA assay and western analysis were performed. To estimate biological activity, 20IU of rhuEpo was subcutaneously injected into four ICR mice. After 8 days, HCT level was increased average 13 per cent, RBC was increased ca. 2${\times}$10$\^$6//${\mu}\ell$. In disease model Rat (anemia c-kit, WSRC-WS/WS), HCT was increased ca. 12%, RBC was increased ca. 1.6${\times}$10$\^$6//${\mu}\ell$. These results suggests that rhEpo we produced has biological activity. To remove glycosylation site by substituting 24, 38, 83, and 126th asparagine (or serine) with glutamic acid, overlapping -extension site-directed mutagenesis was performed. To add novel glycosylation sites, 69, 105th leucine was mutated to asparagine. Mutant EPO construct was transfected into CHO cell. Supernatant of the cell culture was analyzed using ELISA assay with monoclonal anti-EPO antibody (Medac, Germany). Since, several reports for mutagenesis of glycosylation sites showed case-by-case results, we examined both transient expression and stable expression. Addition of novel glycosylation sites resulted no secretion while deletion mutants had little effect except some double deletion mutants (24/83 and 38/83) and triple mutant. We suggest that not single but combination of glycosyl group affect secretion of EPO.

  • PDF

나노 임프린트 공정을 이용한 결정형 실리콘 태양전지 효율 향상 기술 (Technology for Efficiency Enhancement of Crystalline Si Solar Cell using Nano Imprint Process)

  • 조영태;정윤교
    • 한국기계가공학회지
    • /
    • 제12권5호
    • /
    • pp.30-35
    • /
    • 2013
  • In order to increase cell efficiency in crystalline silicon solar cell, reduction of light reflection is one of the essential problem. Until now silicon wafer was textured by wet etching process which has random patterns along crystal orientation. In this study, high aspect ratio patterns are manufactured by nano imprint process and reflectance could be minimized under 1%. After that, screen printed solar cell was fabricated on the textured wafer and I-V characteristics was measured by solar simulator. Consequently cell efficiency of solar cell fabricated using the wafer textured by nano imprint process increased 1.15% than reference solar cell textured by wet etching. Internal quantum efficiency was increased in the range of IR wave length but decreased in the UV wavelength. In spite of improved result, optimization between nano imprinted pattern and solar cell process should be followed.